Gene: COQ10A
Official Full Name: coenzyme Q10Aprovided by HGNC
Gene Summary: Predicted to enable ubiquinone binding activity. Predicted to be involved in cellular respiration. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22383 | COQ10A Knockout cell line (HeLa) | Human | COQ10A | 1:3~1:6 | Negative | Online Inquiry |
KO22384 | COQ10A Knockout cell line (HCT 116) | Human | COQ10A | 1:2~1:4 | Negative | Online Inquiry |
KO22385 | COQ10A Knockout cell line (HEK293) | Human | COQ10A | 1:3~1:6 | Negative | Online Inquiry |
KO22386 | COQ10A Knockout cell line (A549) | Human | COQ10A | 1:3~1:4 | Negative | Online Inquiry |
COQ10A Gene Knockout Cell Lines are sophisticated cellular models specifically engineered to lack the COQ10A gene, which is integral to the biosynthesis of coenzyme Q10 (CoQ10) within the mitochondrial inner membrane. This gene knockout allows researchers to investigate the effects of CoQ10 modulation on various biological processes, particularly those related to mitochondrial function and energy metabolism. By utilizing CRISPR/Cas9 gene-editing technology, these cell lines enable precise alterations at the genomic level, providing an invaluable tool for studying mitochondrial dysfunctions, cellular energy deficits, and related pathologies.
The primary mechanism of the COQ10A knockout involves the disruption of the enzymatic pathway responsible for the synthesis of CoQ10, a crucial component for ATP production and antioxidant defense. Consequently, these cell lines serve as a model to explore the role of CoQ10 in cellular respiration, reactive oxygen species (ROS) production, and overall cellular viability. The implications of these studies are significant, considering that CoQ10 deficiency has been linked to a variety of conditions, including neurodegenerative diseases, cardiovascular disorders, and metabolic syndromes.
From a scientific perspective, the COQ10A Gene Knockout Cell Lines present clear advantages over traditional cell models. Notably, they facilitate targeted studies on COQ10's role without the confounding effects of other cellular processes, allowing for more accurate interpretations of experimental data. Their use can accelerate the discovery of potential therapeutic interventions aimed at replenishing CoQ10 levels in affected tissues, which is of substantial interest in both academic research and clinical trials.
For researchers and clinicians focused on mitochondrial biology, energy metabolism, or oxidative stress, the COQ10A Gene Knockout Cell Lines offer a unique and practical approach to deepen understanding and develop new therapeutic strategies. By leveraging our extensive expertise in genetic engineering and cell line development, we ensure that each product is rigorously validated, providing our clients with reliable, high-quality models that advance scientific research and clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.